Alzheimer's Disease Oral Drop Placebo Kit from United States
This is a measured-dropper bottle kit containing an inert liquid placebo, designed for use in double-blinded clinical trials for Alzheimer's disease, simulating an oral donepezil solution. It is put up in measured doses and is intended for administration to patients in a recognized clinical trial. As a placebo for clinical trial use, it falls under tariff item 3006.93.90, which covers placebos and blinded clinical trial kits not otherwise specified.
Duty Rate — United States → Canada
Import Tips
• Ensure the kit is clearly labelled as a placebo for a recognized clinical trial, with documentation from Health Canada or an ethics board, to support classification under 3006.93.90
• Be prepared to provide the clinical trial protocol and proof of measured doses to CBSA upon request
• Verify if the placebo contains any food-based or beverage-based ingredients, as that could shift classification to a sibling tariff item